NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.

Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval --ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading ...

NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...

QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging ...

SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025.

Aerolib launches Aerolib.app for Physician Advisors, featuring P2P simulations, IP-only search tools, & real-time ...

OpenEvidence released an artificial intelligence-powered medical coding feature embedded in its clinical AI assistant. | ...

MIAMI, March 26, 2026 /PRNewswire/ -- OpenEvidence, the most widely used medical AI and clinical decision-support platform among U.S. physicians, today announced the launch of Coding Intelligence (TM) ...

Corti has launched Symphony for Medical Coding, an agentic AI system built on EMNLP 2025 research that treats coding as a ...

Copenhagen-based Corti has introduced a new AI system designed to tackle one of healthcare’s most persistent operational challenges: medical coding. The company’s latest release, Symphony for Medical ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The legislature in ...